MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about disclosure

06 Dec 2023 Evaluate
Glaxosmithkline Pharmaceuticals has informed that it enclosed disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..